| Childhood acute lymphoblastic leukemia: progress through collaboration CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ... Journal of Clinical Oncology 33 (27), 2938-2948, 2015 | 1004 | 2015 |
| Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Yee, ... Clinical Pharmacology & Therapeutics 89 (3), 387-391, 2011 | 884 | 2011 |
| Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update MV Relling, M Schwab, M Whirl‐Carrillo, G Suarez‐Kurtz, CH Pui, ... Clinical Pharmacology & Therapeutics 105 (5), 1095-1105, 2019 | 562 | 2019 |
| Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer EC Larsen, J Müller, K Schmiegelow, C Rechnitzer, AN Andersen The Journal of Clinical Endocrinology & Metabolism 88 (11), 5307-5314, 2003 | 481 | 2003 |
| NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity T Moriyama, R Nishii, V Perez-Andreu, W Yang, FA Klussmann, X Zhao, ... Nature genetics 48 (4), 367-373, 2016 | 478 | 2016 |
| Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms D Otterness, C Szumlanski, L Lennard, B Klemetsdal, J Aarbakke, ... Clinical Pharmacology & Therapeutics 62 (1), 60-73, 1997 | 471 | 1997 |
| Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008 M Brüggemann, A Schrauder, T Raff, H Pfeifer, M Dworzak, OG Ottmann, ... Leukemia 24 (3), 521-535, 2010 | 454 | 2010 |
| Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia K Schmiegelow, E Forestier, M Hellebostad, M Heyman, J Kristinsson, ... Leukemia 24 (2), 345-354, 2010 | 429 | 2010 |
| Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia A Castor, L Nilsson, I Åstrand-Grundström, M Buitenhuis, C Ramirez, ... Nature medicine 11 (6), 630-637, 2005 | 403 | 2005 |
| Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia N Toft, H Birgens, J Abrahamsson, L Griškevičius, H Hallböök, M Heyman, ... Leukemia 32 (3), 606-615, 2018 | 382 | 2018 |
| Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia J Nordlund, CL Bäcklin, P Wahlberg, S Busche, EC Berglund, ... Genome biology 14, 1-15, 2013 | 370 | 2013 |
| Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation G Gustafsson, K Schmiegelow, E Forestier, N Clausen, A Glomstein, ... Leukemia 14 (12), 2267-2275, 2000 | 340 | 2000 |
| Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group TD Buitenkamp, S Izraeli, M Zimmermann, E Forestier, NA Heerema, ... Blood, The Journal of the American Society of Hematology 123 (1), 70-77, 2014 | 306 | 2014 |
| Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants R Pieters, ML Den Boer, M Durian, G Janka, K Schmiegelow, ... Leukemia 12 (9), 1344-1348, 1998 | 305 | 1998 |
| Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies LL Hjalgrim, T Westergaard, K Rostgaard, K Schmiegelow, M Melbye, ... American journal of epidemiology 158 (8), 724-735, 2003 | 289 | 2003 |
| Advances in individual prediction of methotrexate toxicity: a review K Schmiegelow British journal of haematology 146 (5), 489-503, 2009 | 284 | 2009 |
| Mercaptopurine/methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction K Schmiegelow, SN Nielsen, TL Frandsen, J Nersting Journal of pediatric hematology/oncology 36 (7), 503-517, 2014 | 276 | 2014 |
| Cognitive deficits in long‐term survivors of childhood brain tumors: Identification of predictive factors TS Reimers, S Ehrenfels, EL Mortensen, M Schmiegelow, S Sønderkær, ... Medical and pediatric oncology 40 (1), 26-34, 2003 | 254 | 2003 |
| Use of azathioprine and the risk of cancer in inflammatory bowel disease B Pasternak, H Svanström, K Schmiegelow, T Jess, A Hviid American journal of epidemiology 177 (11), 1296-1305, 2013 | 253 | 2013 |
| Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus K Schmiegelow, A Attarbaschi, S Barzilai, G Escherich, TL Frandsen, ... The Lancet Oncology 17 (6), e231-e239, 2016 | 248 | 2016 |
